These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 11606666)
1. A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies. Yoshita M; Taki J; Yamada M J Neurol Neurosurg Psychiatry; 2001 Nov; 71(5):583-8. PubMed ID: 11606666 [TBL] [Abstract][Full Text] [Related]
2. (123)I-MIBG myocardial scintigraphy and neurocirculatory abnormalities in patients with dementia with Lewy bodies and Alzheimer's disease. Kim JS; Park HE; Oh YS; Song IU; Yang DW; Park JW; Lee KS J Neurol Sci; 2015 Oct; 357(1-2):173-7. PubMed ID: 26208800 [TBL] [Abstract][Full Text] [Related]
3. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease. Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438 [TBL] [Abstract][Full Text] [Related]
4. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies]. Orimo S Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627 [TBL] [Abstract][Full Text] [Related]
5. 123I-metaiodobenzylguanidine myocardial scintigraphy with early images alone is useful for the differential diagnosis of dementia with Lewy bodies. Manabe Y; Inui Y; Toyama H; Kosaka K Psychiatry Res Neuroimaging; 2017 Mar; 261():75-79. PubMed ID: 28152401 [TBL] [Abstract][Full Text] [Related]
6. Decreased cardiac MIBG uptake, its correlation with clinical symptoms in dementia with Lewy bodies. Kobayashi S; Tateno M; Morii H; Utsumi K; Saito T Psychiatry Res; 2009 Oct; 174(1):76-80. PubMed ID: 19766460 [TBL] [Abstract][Full Text] [Related]
7. Cardiac (123)I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease. Watanabe H; Ieda T; Katayama T; Takeda A; Aiba I; Doyu M; Hirayama M; Sobue G J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):781-3. PubMed ID: 11385013 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis. Slaets S; Van Acker F; Versijpt J; Hauth L; Goeman J; Martin JJ; De Deyn PP; Engelborghs S Int J Geriatr Psychiatry; 2015 Aug; 30(8):864-9. PubMed ID: 25363642 [TBL] [Abstract][Full Text] [Related]
9. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease. Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056 [TBL] [Abstract][Full Text] [Related]
10. The role of 123I-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic. Hanyu H; Shimizu S; Hirao K; Sakurai H; Iwamoto T; Chikamori T; Hida S; Yamashina A; Koizumi K; Abe K Dement Geriatr Cogn Disord; 2006; 22(5-6):379-84. PubMed ID: 16960446 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic markers for diagnosing dementia with Lewy bodies: CSF and MIBG cardiac scintigraphy study. Wada-Isoe K; Kitayama M; Nakaso K; Nakashima K J Neurol Sci; 2007 Sep; 260(1-2):33-7. PubMed ID: 17459416 [TBL] [Abstract][Full Text] [Related]
12. [Dementia with Lewy bodies and Alzheimer's disease: differential diagnosis by cardiac sympathetic innervation MIBG imaging]. Estorch M; Camacho V; Fuertes J; Rodríguez-Revuelto A; Hernández MA; Flotats A; Kulisevsky J; Carrió I Rev Esp Med Nucl; 2006; 25(4):229-35. PubMed ID: 16827985 [TBL] [Abstract][Full Text] [Related]
13. Usefulness of [123I]metaiodobenzylguanidine ([123I]MIBG) myocardial scintigraphy in differentiating between Alzheimer's disease and dementia with Lewy bodies. Oide T; Tokuda T; Momose M; Oguchi K; Nakamura A; Ohara S; Ikeda S Intern Med; 2003 Aug; 42(8):686-90. PubMed ID: 12924492 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study. Yoshita M; Arai H; Arai H; Arai T; Asada T; Fujishiro H; Hanyu H; Iizuka O; Iseki E; Kashihara K; Kosaka K; Maruno H; Mizukami K; Mizuno Y; Mori E; Nakajima K; Nakamura H; Nakano S; Nakashima K; Nishio Y; Orimo S; Samuraki M; Takahashi A; Taki J; Tokuda T; Urakami K; Utsumi K; Wada K; Washimi Y; Yamasaki J; Yamashina S; Yamada M PLoS One; 2015; 10(3):e0120540. PubMed ID: 25793585 [TBL] [Abstract][Full Text] [Related]
15. Potential diagnostic value of Abbasi M; Ghalandari N; Farzanefar S; Aghamollaii V; Ahmadi M; Ganji M; Afarideh M; Loloee S; Naseri M; Tafakhori A Clin Neurol Neurosurg; 2017 Dec; 163():163-166. PubMed ID: 29112909 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the usefulness of brain perfusion SPECT and MIBG myocardial scintigraphy for the diagnosis of dementia with Lewy bodies. Tateno M; Kobayashi S; Shirasaka T; Furukawa Y; Fujii K; Morii H; Yasumura S; Utsumi K; Saito T Dement Geriatr Cogn Disord; 2008; 26(5):453-7. PubMed ID: 18974648 [TBL] [Abstract][Full Text] [Related]
17. Differentiation of dementia with Lewy bodies, Alzheimer's disease and vascular dementia by cardiac 131I-meta-iodobenzylguanidine (MIBG) uptake (preliminary report). Jindahra P; Vejjajiva A; Witoonpanich R; Sirisriro R; Sritara C; Pulkes T J Med Assoc Thai; 2004 Oct; 87(10):1176-81. PubMed ID: 15560694 [TBL] [Abstract][Full Text] [Related]
18. (123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies. Orimo S; Yogo M; Nakamura T; Suzuki M; Watanabe H Ageing Res Rev; 2016 Sep; 30():122-33. PubMed ID: 26835846 [TBL] [Abstract][Full Text] [Related]